CABP2 and Hearing impairment: Deletion of CaBP2 results in an early-onset, progressive hearing impairment in the KO mouse model and moderate to severe hearing impairment, DFNB93, in affected human patients (Picher, 2017; Koohiyan, 2019; Schrauwen et al., 2012).